PolyPid Ltd. (PYPD)
- Insider Monkey
PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript
PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript May 9, 2024 PolyPid Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you all for participating in PolyPid’s First Quarter 2024 Earnings Conference Call. Joining me on the call today […]
- GlobeNewswire
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
More Than 200 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Approximately 50 Centers Currently Open Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024 Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Com
- GlobeNewswire
PolyPid to Participate in Citizens JMP Life Sciences Conference
PETACH TIKVA, Israel, May 01, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that company management will present at the Citizens JMP Life Sciences Conference taking place in New York, NY, from May 13 – 14, 2024. Citizens JMP Life Sciences Conference PresentationDate: Monday, May 13, 2024Time:2:30 PM ET The PolyPid management team will participate in one-on-one investor meeting
